7th Cancer Therapeutics and Partnering Summit
In-Person Event
Aug 28 - 29, 2018
San Diego, California, USAOVERVIEW
7th Cancer Therapeutics and Partnering Summit is organized by Global Technology Community (GTC) and will be held during Aug 28 - 29, 2018 at San Diego, California, United States of America. The target audience for this medical event is Oncologists.
Conference Description :
This summit includes three tracks focused on both the research, and business perspectives in oncology. This summit will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials working to identify and exploit advances in the field of oncology in order to deliver products with a meaningful clinical impact. In addition, industry leaders from big pharma and various biotech/pharmaceutical companies, including business/corporate development executives, licensing executives, global alliance, and venture capitalists, will all be present to explore potential collaborations and learn about relevant issues in oncology.
Focus areas include cancer diagnostics, cancer immunotherapy, as well as partnering and deal-making in oncology. Discussion topics include emerging targets, therapeutic strategies, next generation sequencing in cancer diagnosis, progress in cancer immunotherapy, combination strategies in immuno-oncology, advancements in technology, as well as business development trends, markets, partnership opportunities, and access to capital market. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer!
Session Topics:
Complementary & Companion Diagnostics in Oncology
• Technologies and Biomarkers
• Case Studies for Development and Commercialization
Cancer Immunotherapy
• Precision Medicine and Immunomodulatory Antibodies
• Combination Immunotherapy and Novel Targets
Oncology Partnering & Deal-Making
• What’s New in Oncology – Targets, Models, Assays
• Partnering between Pharma, Biotech, Academic Groups and CROs to Advance Research
• Oncology Perspectives from Venture Capital & Public Markets
• Technology Transfer & Licensing: Challenges & Opportunities
Additional details will be posted as soon as they are available.
Conference Description :
This summit includes three tracks focused on both the research, and business perspectives in oncology. This summit will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials working to identify and exploit advances in the field of oncology in order to deliver products with a meaningful clinical impact. In addition, industry leaders from big pharma and various biotech/pharmaceutical companies, including business/corporate development executives, licensing executives, global alliance, and venture capitalists, will all be present to explore potential collaborations and learn about relevant issues in oncology.
Focus areas include cancer diagnostics, cancer immunotherapy, as well as partnering and deal-making in oncology. Discussion topics include emerging targets, therapeutic strategies, next generation sequencing in cancer diagnosis, progress in cancer immunotherapy, combination strategies in immuno-oncology, advancements in technology, as well as business development trends, markets, partnership opportunities, and access to capital market. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer!
Session Topics:
Complementary & Companion Diagnostics in Oncology
• Technologies and Biomarkers
• Case Studies for Development and Commercialization
Cancer Immunotherapy
• Precision Medicine and Immunomodulatory Antibodies
• Combination Immunotherapy and Novel Targets
Oncology Partnering & Deal-Making
• What’s New in Oncology – Targets, Models, Assays
• Partnering between Pharma, Biotech, Academic Groups and CROs to Advance Research
• Oncology Perspectives from Venture Capital & Public Markets
• Technology Transfer & Licensing: Challenges & Opportunities
Additional details will be posted as soon as they are available.
KEY DATES
28 Aug, 2018
Event Start Date
29 Aug, 2018
Event End Date
SPECIALITIES
OncologySUGGESTED HOTELS
CONFERENCE VENUE
TBDRELATED CONFERENCES & LIVE WEBINARS
Quick Links